Letter | Published:

Dopamine modulates cholecystokinin release in neostriatum

Nature volume 301, pages 338340 (27 January 1983) | Download Citation

Subjects

Abstract

Peptides of the cholecystokinin family, but mainly the sulphated octapeptide (CCK8), have been found in brain extracts of several species1–6. High amounts are present in axons and nerve endings in the rat neostriatum (caudate-putamen)7,8 and a role for cholecystokinin as a neurotransmitter in this functionally important area is possible9,10. We have incubated slices of rat caudate-putamen (CP) to study the release of cholecystokinin-immunoreactivity (CCK-IR) in vitro. The release of CCK-IR was induced by veratridine. It was dependent on the presence of Ca2+ in the incubation medium and was blocked by tetrodotoxin. We now present evidence that dopaminergic agonists added to the slices modulate the veratridine-induced release via different groups of receptors. Receptors which mediate an enhancement of the release of CCK-IR seem to be located on afferent axons and nerve endings and are possibly of the D-2 subtype. Receptors which mediate an attenuation of the release are probably situated on cells intrinsic to the CP. These receptors seem to be coupled to adenylate cyclase and might thus be of the D-1 subtype. There is also evidence that endogenous dopamine when released enhances the secretion of CCK-IR.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , & Nature 257, 604–605 (1975).

  2. 2.

    Nature 264, 568–570 (1976).

  3. 3.

    , , , & Nature 274, 711–713 (1978).

  4. 4.

    J. biol. Chem. 253, 4022–4030 (1978).

  5. 5.

    , , & Proc. natn. Acad. Sci. U.S.A. 78, 3892–3896 (1981).

  6. 6.

    , , , & Brain Res. 212, 51–57 (1981).

  7. 7.

    , , & Histochemistry 59, 249–257 (1979).

  8. 8.

    , , & Proc. natn. Acad. Sci. U.S.A. 77, 1190–1194 (1980).

  9. 9.

    , , , & Fedn Proc. 38, 2325–2329 (1979).

  10. 10.

    , & Life Sci. 25, 339–342 (1979).

  11. 11.

    , , & Science 215, 187–188 (1982).

  12. 12.

    , & J. comp. Neurol. 180, 301–324 (1978).

  13. 13.

    , , & Nature 271, 766–768 (1978).

  14. 14.

    & Nature 277, 93–96 (1979).

  15. 15.

    Pharmac. Rev. 32, 229–313 (1980).

  16. 16.

    Psychopharmacology 75, 217 (1981).

  17. 17.

    , & Proc. natn. Acad. Sci. U.S.A. 69, 2145–2149 (1972).

  18. 18.

    Science 188, 1084–1089 (1975).

  19. 19.

    , & Brain Res. 151, 507–521 (1978).

  20. 20.

    , , , & Molec. Pharmac. 12, 639–648 (1976).

  21. 21.

    in Handbook of Psychopharmacology Vol. 5 (eds Iversen, L. L., Iversen, S. D. & der, S. H.) 131–194 (Plenum, New York, 1975).

Download references

Author information

Affiliations

  1. Department of Pharmacology, University of Freiburg, Hermann-Herderstr. 5, D-7800 Freiburg i. Br., FRG

    • Dieter K. Meyer
    •  & Joachim Krauss

Authors

  1. Search for Dieter K. Meyer in:

  2. Search for Joachim Krauss in:

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/301338a0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.